Skip to Content

Quest Diagnostics Incorporated (NYSE: DGX)

Securities Class Action

  • Date:
  • 6/9/2019
  • Company Name:
  • Quest Diagnostics Incorporated
  • Stock Symbol:
  • DGX

Case Finder

Locate any case using the tools below.

NEW YORK, June 9, 2019 – Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Quest Diagnostics Incorporated (NYSE: DGX).

On June 3, 2019, the Company disclosed that it had been notified by a billing services vendor that, between August 1, 2018 and March 30, 2019, an unauthorized user had gained access to data for nearly 11.9 million patients, including credit card numbers and bank account information.

If you purchased or otherwise acquired Quest Diagnostics shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Quest Diagnostics Incorporated . BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: